Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V W Armstrong

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
Transplantation Proceedings|October 8, 2003
C2 monitoring and absorption profiling of cyclosporine for optimization of immunosuppressive therapy in pediatric renal transplant recipientsL T Weber, M Shipkova, V W Armstrong, et al.
Clinical Chemistry|March 7, 2000
Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and EmitM Shipkova, E Schütz, V W Armstrong, et al.
Clinical Chemistry|May 26, 2001
No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipientsN von Ahsen, M Richter, C Grupp, et al.
Transplantation Proceedings|December 26, 2001
Comparison of trough level and C(2) cyclosporine blood concentration monitoring in outpatient kidney transplant recipientsF Braun, V W Armstrong, T Lorf, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|November 9, 2002
First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality managementV Schettler, E Wieland, V W Armstrong, et al.
Therapeutic Drug Monitoring|February 25, 2000
Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant RecipientsM Oellerich, M Shipkova, E Schütz, et al.
Journal of Lipid Research|December 1, 1991
Contribution of the apo[a] phenotype to plasma Lp[a] concentrations shows considerable ethnic variationM Helmhold, J Bigge, R Muche, et al.
The Journal of Biological Chemistry|March 17, 1995
Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a)A Ernst, M Helmhold, C Brunner, et al.
ASAIO Transactions|July 1, 1986
Selective continuous elimination of low density lipoproteins (LDL) by heparin precipitation: first clinical applicationT Eisenhauer, V W Armstrong, H Wieland, et al.
Therapeutic Drug Monitoring|June 1, 1994
Influence of gender on the monoethylglycinexylidide test in normal subjects and liver donorsM Oellerich, E Schütz, F Polzien, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Transplantation Proceedings|October 8, 2003
C2 monitoring and absorption profiling of cyclosporine for optimization of immunosuppressive therapy in pediatric renal transplant recipientsL T Weber, M Shipkova, V W Armstrong, et al.
Clinical Chemistry|March 7, 2000
Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and EmitM Shipkova, E Schütz, V W Armstrong, et al.
Clinical Chemistry|May 26, 2001
No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipientsN von Ahsen, M Richter, C Grupp, et al.
Transplantation Proceedings|December 26, 2001
Comparison of trough level and C(2) cyclosporine blood concentration monitoring in outpatient kidney transplant recipientsF Braun, V W Armstrong, T Lorf, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|November 9, 2002
First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality managementV Schettler, E Wieland, V W Armstrong, et al.
Therapeutic Drug Monitoring|February 25, 2000
Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant RecipientsM Oellerich, M Shipkova, E Schütz, et al.
Journal of Lipid Research|December 1, 1991
Contribution of the apo[a] phenotype to plasma Lp[a] concentrations shows considerable ethnic variationM Helmhold, J Bigge, R Muche, et al.
The Journal of Biological Chemistry|March 17, 1995
Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a)A Ernst, M Helmhold, C Brunner, et al.
ASAIO Transactions|July 1, 1986
Selective continuous elimination of low density lipoproteins (LDL) by heparin precipitation: first clinical applicationT Eisenhauer, V W Armstrong, H Wieland, et al.
Therapeutic Drug Monitoring|June 1, 1994
Influence of gender on the monoethylglycinexylidide test in normal subjects and liver donorsM Oellerich, E Schütz, F Polzien, et al.
Pageof 15